Clinical Assessment of a HYDRAGLYDE® Regimen

NACompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

August 18, 2017

Study Completion Date

August 18, 2017

Conditions
Refractive ErrorsMyopiaHypermetropia
Interventions
DEVICE

Lotrafilcon B contact lenses with added wetting agent

Silicone hydrogel contact lenses

DEVICE

Samfilcon A contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent

Multi-purpose disinfecting solution for contact lens care

DEVICE

Hydrogen peroxide-based contact lens solution with added wetting agent

Solution for contact lens cleaning and disinfecting

DEVICE

Senofilcon C contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

Senofilcon A contact lenses

Habitual silicone hydrogel contact lenses with a replacement pair issued after 2 weeks

DEVICE

Comfilcon A contact lenses

Habitual silicone hydrogel contact lenses

DEVICE

Habitual Multi-Purpose Solution (HMPS)

Multi-purpose solution for contact lens care according to participant's habitual brand, used per manufacturer's instructions

Trial Locations (8)

31134

Alcon Investigative Site, Hildesheim

35233

Alcon Investigative Site, Birmingham

38104

Alcon Investigative Site, Memphis

43210

Alcon Investigative Site, Columbus

44106

Alcon Investigative Site, Cleveland

77204

Alcon Investigative Site, Houston

N2L3G1

Alcon Investigative Site, Waterloo

07745

Alcon Investigative Site, Jena

All Listed Sponsors
lead

Alcon, a Novartis Company

INDUSTRY

NCT03026257 - Clinical Assessment of a HYDRAGLYDE® Regimen | Biotech Hunter | Biotech Hunter